Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership69,700 shares
Latest Disclosed Value $ 481,627
Strs Ohio reports 23,133.33% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 69,700 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $400,775 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 300 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 23,133.33% during the quarter. The current value of the position is $366,622 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F VANDA PHARMACEUTICALS COM_STK 921659108 69,700 69,400 23,133.33 482 23,950.00 0.0019
2026-02-02 2025-12-31 13F VANDA PHARMACEUTICALS COM_STK 921659108 300 0 0.00 3 100.00 0.0000
2025-10-30 2025-09-30 13F VANDA PHARMACEUTICALS COM_STK 921659108 300 0 0.00 1 0.00 0.0000
2025-08-04 2025-06-30 13F VANDA PHARMACEUTICALS COM_STK 921659108 300 0 0.00 1 0.00 0.0000
2025-05-28 2025-03-31 13F VANDA PHARMACEUTICALS COM_STK 921659108 300 -40,800 -99.27 1 -99.49 0.0000
2025-05-28 2024-12-31 13F VANDA PHARMACEUTICALS COM_STK 921659108 41,100 0 0.00 197 2.08 0.0008
2024-11-01 2024-09-30 13F VANDA PHARMACEUTICALS COM_STK 921659108 41,100 0 0.00 193 -17.24 0.0007
2024-08-05 2024-06-30 13F VANDA PHARMACEUTICALS COM_STK 921659108 41,100 4,200 11.38 232 0.0009
2024-05-13 2024-03-31 13F VANDA PHARMACEUTICALS COM_STK 921659108 36,900 -21,100 -36.38 0 0.0006
2024-01-30 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 58,000 0 0.00 0 0.0010
2023-10-26 2023-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 58,000 0 0.00 0 0.0011
2023-10-26 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 58,000 0 0 0.0011
2023-07-31 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 58,000 4,500 8.41 0 0.0016
2023-08-02 2023-03-31 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 53,500 0 0.00 0 0.0016
2023-08-02 2023-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 53,500 0 0 0.0016
2023-04-27 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 53,500 0 0 0.0019
2023-01-26 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 53,500 7,900 17.32 0 -100.00 0.0018
2022-10-27 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 45,600 0 0.00 450 -9.46 0.0021
2022-07-25 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 45,600 2,600 6.05 497 2.26 0.0022
2022-04-21 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 43,000 24,900 137.57 486 71.73 0.0018
2022-01-24 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 18,100 -700 -3.72 283 -12.11 0.0010
2021-10-22 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 18,800 0 0.00 322 -20.30 0.0012
2021-07-26 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 18,800 1,800 10.59 404 58.43 0.0015
2021-04-23 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 17,000 -14,400 -45.86 255 -38.11 0.0010
2021-01-25 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 31,400 -32,100 -50.55 412 -32.79 0.0016
2020-12-14 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 63,500 11,400 21.88 613 2.85 0.0026
2020-07-23 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 52,100 -6,000 -10.33 596 -0.83 0.0026
2020-04-23 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 58,100 12,000 26.03 601 -20.50 0.0032
2020-01-24 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 46,100 -6,100 -11.69 756 9.09 0.0032
2019-10-21 2019-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 52,200 1,400 2.76 693 -3.08 0.0030
2019-10-21 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 52,200 6,100 693 3,067.2564
2019-07-25 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 50,800 8,300 19.53 715 -8.57 0.0032
2019-04-19 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 42,500 9,400 28.40 782 -9.49 0.0035
2019-01-23 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 33,100 -7,900 -19.27 864 -8.09 0.0044
2018-10-19 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 41,000 -6,500 -13.68 940 3.98 0.0041
2018-08-06 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 47,500 4,200 9.70 904 24.01 0.0039
2018-04-20 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 43,300 -12,900 -22.95 729 -14.64 0.0032
2018-01-23 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 56,200 12,100 27.44 854 8.24 0.0036
2017-10-23 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 44,100 -3,900 -8.12 789 0.90 0.0034
2017-07-26 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 48,000 -1,600 -3.23 782 12.68 0.0035
2017-04-26 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 49,600 2,200 4.64 694 -8.20 0.0030
2017-01-24 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 47,400 3,200 7.24 756 2.86 0.0033
2016-10-27 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 44,200 -17,500 -28.36 735 6.52 0.0033
2016-07-26 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 61,700 -14,927 -19.48 690 7.81 0.0031
2016-04-25 2016-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 76,627 76,627 0.00 640 0.0029
2015-04-27 2015-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 0 -60,100 -100.00 0 -100.00
2015-01-23 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 60,100 -4,400 -6.82 861 28.51 0.0037
2014-10-29 2014-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 64,500 40,800 172.15 670 74.93 0.0030
2014-10-20 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 64,500 670
2014-07-24 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 23,700 1,600 7.24 383 6.69 0.0017
2014-04-28 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 22,100 4,700 27.01 359 66.20 0.0016
2014-01-30 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 17,400 -2,000 -10.31 216 1.41 0.0010
2013-10-24 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 19,400 10,500 117.98 213 195.83 0.0009
2013-08-12 2013-06-30 13F VANDA PHARMACEUTICALS COM 921659108 8,900 8,900 72 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.